- Home
- / Correvio Pharma
- / Financials
Header placeholder lorem ipsum dolor sit amet, consectetur adipiscing elit.
Correvio Pharma financials data including stock price, CreditSafe score, income statement, balance sheet, and cash flow.
Revenue
$32.6 M
FY, 2019
CreditSafe Score
?
Score changed on Jul 04, 2026
Premium Content only available in Craft’s Intelligence Portal
View 30+ financial ratio metrics including price-to-earnings ratio, debt-to-assets ratio, gross profit margin, and more.
Financial ratio metrics help evaluate the financial strength of a company, and help raise red flags that can indicate potential risk, fulfillment challenges, or even possible bankruptcy.
Learn moreFinancial Statements
| USD | FY, 2018 | FY, 2019 |
|---|---|---|
| Revenue | 28.7M | 32.6M |
| Cost of goods sold | 8.3M | 9.8M |
| Gross profit | 20.4M | 22.8M |
| Gross profit margin, % | 69.9% | |
| Operating expense total | 42.6M | 46.3M |
| Depreciation and amortization | 4.1M | 3.9M |
| EBITDA | (22.2M) | (23.5M) |
| EBITDA margin, % | -72.0% | |
| EBIT | (8.4M) | (27.8M) |
| EBIT margin, % | -85.1% | |
| Interest expense | 6.0M | 7.5M |
| Pre tax profit | (16.5M) | (35.0M) |
| Income tax expense | 38.0K | 179.0K |
| Net Income | (16.6M) | (35.2M) |